Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
18,580,860
-
Total 13F shares
-
11,735,029
-
Share change
-
+386,186
-
Total reported value
-
$101,625,415
-
Put/Call ratio
-
208%
-
Price per share
-
$8.66
-
Number of holders
-
87
-
Value change
-
+$5,707,089
-
Number of buys
-
42
-
Number of sells
-
43
Institutional Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q1 2025
As of 31 Mar 2025,
OptimizeRx Corp - Common Stock (OPRX) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,735,029 shares.
The largest 10 holders included
Whetstone Capital Advisors, LLC, BlackRock, Inc., ROYCE & ASSOCIATES LP, VANGUARD GROUP INC, BLAIR WILLIAM & CO/IL, RICE HALL JAMES & ASSOCIATES, LLC, KENNEDY CAPITAL MANAGEMENT LLC, Parkman Healthcare Partners LLC, DIMENSIONAL FUND ADVISORS LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
87
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.